VITA 34 AG - Asset Resilience Ratio

Latest as of September 2025: 1.10%

VITA 34 AG (V3V) has an Asset Resilience Ratio of 1.10% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read V3V total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€1.76 Million
≈ $2.05 Million USD Cash + Short-term Investments

Total Assets

€159.53 Million
≈ $186.51 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how VITA 34 AG's Asset Resilience Ratio has changed over time. See what is VITA 34 AG's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down VITA 34 AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see V3V stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €1.76 Million 1.1%
Total Liquid Assets €1.76 Million 1.10%

Asset Resilience Insights

  • Limited Liquidity: VITA 34 AG maintains only 1.10% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

VITA 34 AG Industry Peers by Asset Resilience Ratio

Compare VITA 34 AG's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Chemed Corp
NYSE:CHE
Medical Care Facilities 14.55%
Top Choice Medical Investment Co Inc
SHG:600763
Medical Care Facilities 0.02%
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
Medical Care Facilities 29.80%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%
Ramsay Health Care Ltd
AU:RHC
Medical Care Facilities 3.49%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%
Freedom Care Group Holdings Ltd
AU:FCG
Medical Care Facilities 0.39%

Annual Asset Resilience Ratio for VITA 34 AG (2007–2024)

The table below shows the annual Asset Resilience Ratio data for VITA 34 AG.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 1.07% €1.64 Million
≈ $1.92 Million
€152.74 Million
≈ $178.57 Million
+0.02pp
2023-12-31 1.05% €1.66 Million
≈ $1.94 Million
€158.36 Million
≈ $185.14 Million
-10.98pp
2022-12-31 12.03% €18.23 Million
≈ $21.32 Million
€151.51 Million
≈ $177.13 Million
-7.84pp
2021-12-31 19.88% €35.37 Million
≈ $41.36 Million
€177.95 Million
≈ $208.04 Million
+1.89pp
2020-12-31 17.99% €10.52 Million
≈ $12.29 Million
€58.46 Million
≈ $68.35 Million
+2.91pp
2019-12-31 15.08% €9.21 Million
≈ $10.77 Million
€61.10 Million
≈ $71.43 Million
+3.12pp
2018-12-31 11.96% €7.09 Million
≈ $8.29 Million
€59.32 Million
≈ $69.35 Million
+4.92pp
2017-12-31 7.04% €4.36 Million
≈ $5.10 Million
€61.96 Million
≈ $72.44 Million
-0.92pp
2016-12-31 7.95% €3.45 Million
≈ $4.04 Million
€43.42 Million
≈ $50.76 Million
+5.58pp
2015-12-31 2.38% €1.04 Million
≈ $1.22 Million
€43.78 Million
≈ $51.19 Million
-1.71pp
2010-12-31 4.09% €1.50 Million
≈ $1.75 Million
€36.69 Million
≈ $42.89 Million
-2.33pp
2009-12-31 6.42% €2.00 Million
≈ $2.34 Million
€31.15 Million
≈ $36.42 Million
+3.53pp
2008-12-31 2.89% €876.00K
≈ $1.02 Million
€30.31 Million
≈ $35.43 Million
-3.16pp
2007-12-31 6.05% €1.95 Million
≈ $2.28 Million
€32.26 Million
≈ $37.71 Million
--
pp = percentage points

About VITA 34 AG

XETRA:V3V Germany Medical Care Facilities
Market Cap
$90.49 Million
€77.40 Million EUR
Market Cap Rank
#19574 Global
#1797 in Germany
Share Price
€4.44
Change (1 day)
-1.33%
52-Week Range
€3.90 - €7.45
All Time High
€17.30
About

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and… Read more